GlaxoSmithKline (GSK) is a research-based pharmaceutical and healthcare company engaged in pharmaceutical products, vaccines, over-the-counter (OTC) medicines and health-related consumer products. GSK is involved in four major therapeutic areas - anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic. 
The company will focus on its key strategies of optimising the performance of marketed products, delivering the product pipeline for patients, improving access to medicines and maximising total shareholder return. Sales growth of existing products and launch of new products are key drivers of GSK’s business performance. It says that it is mitigating the impact of generic competition by introducing improved versions of established medicines and driving growth of its other key products.
GSK is addressing the key challenges that face both the pharmaceutical industry and consumer healthcare industry as a whole by improving productivity in R&D and ensuring patients have access to new medicines. Challenges remain in intellectual property rights from developing countries and threaten the pharmaceutical industry's traditional business model.
GSK has over 99,003 employees worldwide and its headquarters are in Brentford, UK. In 2008, it had sales of £24bn.
ICIS Chemical Business magazine has unveiled the ICIS Top 100 Chemical Companies, with rankings based on 2008 sales.
A PDF of the ICIS Top 100 Chemical Companies is available for download on ICIS connect.
See the article and analysis of the ICIS Top 100 on ICIS news.
Key Personnel
Non-executive chairman: Christopher Gent
Chief executive officer: Andrew Witty
Chief financial officer: Julian Heslop
Non-executive director: Roy Anderson
Non-executive director: Crispin Davis
Non-executive director: Stephanie Burns
Non-executive director: Lawrence Culp
Non-executive director: Deryck Maughan
Non-executive director: James Murdoch
Non-executive director: Daniel Podolsky
Non-executive Director: Tom de Swaan
Non-executive director: Robert Wilson
Chairman (R&D): Moncef Slaoui
(Updated October 2009)
Contacts
GlaxoSmithKline plc
980 Great West Road
Brentford
Middlesex TW8 9GS
UK
Tel: +44 20 8047 5000
www.gsk.com
GlaxoSmithKline
Company Structure
GlaxoSmithKline (GSK) is a research-based pharmaceutical and healthcare company engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, vaccines, over-the-counter (OTC) medicines and health-related consumer products. GlaxoSmithKline was formed on 27 December 2000 through the merger of Glaxo Wellcome and SmithKline Beecham, both UK-based companies.
More about GlaxoSmithKline Structure
GlaxoSmithKline
Strategy & Financial Highlights
GlaxoSmithKline (GSK) states that it will address these challenges through three key strategic priorities that it believes will transform GSK into a company that delivers “more growth, less risk and an improved financial performance”. ICIS also provides you with key financial data listed in table form.
More about GlaxoSmithKline Strategy & Financial Highlights
News:
Get news on GlaxoSmithKline plus the latest chemical news, information, data, market movements and analysis
in one place with ICIS news
Search:
Find details on other chemical companies and suppliers with
ICIS search
Newsletters:
ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.
Plants and projects:
Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database